KTTAW

Pasithea Therapeutics Corp. [KTTAW] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

KTTAW Stock Summary

In the News

KTTAW Financial details

Company Rating
-
Market Cap
8.55M
Income
-287.56M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
8
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-609.67
Forward P/E
-
PEG
-2.98
P/S
30.04
P/B
6154.22
P/C
-
P/FCF
-0.46
Quick Ratio
9.63
Current Ratio
10.16
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-221.65
EPS next Y
-
EPS next Q
-
EPS this Y
25.82%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
68.99%
-
-
-
-
SMA20
50%
SMA50
50%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-934%
ROE
-787%
ROC
-0.56%
Gross Margin
101%
Oper. Margin
-6610%
Profit Margin
-118986%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.015-0.015
52W High
-
52W Low
-
RSI
44.7
Rel Volume
-
Avg Volume
-
Volume
8K
Perf Week
-41.09%
Perf Month
1.99%
Perf Quarter
-
Perf Half Y
3.54%
-
-
-
-
Beta
0.884
-
-
Volatility
0%, 0.01%
Prev Close
0%
Price
0.0205
Change
-7.24%

Something similar

Top by Market Cap
MSF.DE
VTSAX
3V64.DE
EMBASSY.NS
META
Same Sector
COX.PA
DIGN.ST
CVM
8372.HK
BTAI
Check Those
VLSFINANCE.NS
IONI
MLSR.TA
002310.SZ
DHAC
Similar Market Cap
CHIL
TLLYF
HEIQ.L
CYAD.BR
YTEN

Company Profile

Healthcare Biotechnology
  • Market Capitalization 8.55M
  • Employee 8
  • CEO Dr. Tiago Reis Marques M.D., Ph.D.
  • Headquarters Miami Beach,FL,US
  • IPO Date 2021-09-15
  • Website http://pasitheaclinics.com

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.